In 2014, the Albumin Italian Outcome Sepsis (ALBIOS) study, a large multicenter open-label randomized controlled trial, showed that in patients with severe sepsis, resuscitation with 20% albumin and crystalloids did not improve survival compared to crystalloids alone. The gene discussed is ALB; the disease is Sepsis.